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Abstract
Birth weight manipulation is common in per-case hospital reimbursement sys-
tems, in which hospitals receive more money for otherwise equal newborns with
birth weight just below compared to just above specific birth weight thresholds. As
hospitals receive more money for cases with weight below the thresholds, having
a (reported) weight below a threshold could benefit the newborn. Also, these re-
imbursement thresholds overlap with diagnostic thresholds that have been shown to
affect the quantity and quality of care that newborns receive. Based on the universe of
hospital births in Germany from the years 2005–2011, we investigate whether weight
below reimbursement relevant thresholds triggers different quantity and quality of
care. We find that this is not the case, suggesting that hospitals’ financial incentives
with respect to birth weight do not directly impact the care that newborns receive.
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1 Introduction
Small changes in birth weight can have important financial implications for hospitals in
many of the widespread prospective payment schemes (PPS) which reimburse hospitals
with a fixed rate for the treatment of strictly defined diagnosis related groups (DRGs).
More specifically, hospitals receive a higher reimbursement for newborns with birth weight
just below certain thresholds than for newborns with weight above, leading to an incentive
to under-report birth weight. The evidence is accruing that the introduction of birth
weight thresholds has led to large under-reporting – so called upcoding – of birth weight
(e.g. Jürges and Köberlein 2015; Shigeoka and Fushimi 2014).
At the same time, birth weight thresholds are used to diagnose newborns as having
“extremely low” (weight ≤ 1000g), “very low” (weight ≤ 1500g), or “low” birth weight
(weight ≤ 2500g) and appear in medical guidelines. Despite the fact that low birth weight
is typically linked to worse health outcomes (see e.g. Hack et al. (2002), Hummer et al.
(2014)), newborns with weight just below the 1500g diagnostic threshold have been found
to have higher survival chances than newborns with weight just above (Almond et al.
2010; Bharadwaj et al. 2013; Breining et al. 2015). To the extent that reimbursement-
relevant birth weight thresholds are identical to the diagnostic thresholds, the practice
of upcoding newborns’ weight may thus be to the benefit of the newborn. Furthermore,
as the hospital receives more money for newborns with weight below the reimbursement
relevant thresholds, they may also be able or willing to deliver additional care to these
newborns.
In this paper, we investigate whether newborns benefit from having a reported birth
weight below reimbursement relevant weight thresholds in the German DRG system.
Based on an administrative hospital claims data set covering the universe of hospital births
in Germany in the years 2005–2011, we compare the survival chances and the quantity
of care that newborns with weight just below the relevant thresholds receive to those of
newborns with weight just above the thresholds. We include all eight reimbursement rel-
evant thresholds in the German DRG system. While some of these thresholds overlap with
the diagnostic thresholds and/or are explicitly mentioned in medical guidelines, others are
only relevant for reimbursement, allowing us to shed light on the importance of diagnostic
thresholds, medical guidelines, and reimbursement for the care of newborns.
Different from the settings in the earlier literature on the effects of diagnostic thresholds
(Almond et al. 2010; Bharadwaj et al. 2013; Breining et al. 2015), the fact that the dia-
gnostic thresholds are relevant for reimbursement in our setting imposes a challenge to
the empirical analysis: If the decision to upcode a newborn’s weight below a threshold
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depends on the newborn’s health status, the crucial assumption that newborns with re-
ported weight above and below the threshold have ex ante similar health is not plausible,
an issue that Barreca et al. (2011) already raised in the light of the earlier literature. As
Jürges and Köberlein (2015) show, it is likely that birth weight manipulation in German
hospitals is not random. To the contrary, hospitals primarily tend to upcode newborns
for whom staff expects more care. These are relatively fragile newborns that still have
non-negligible survival chances and will therefore receive a lot of treatment. We take three
steps in our analysis to take this into account: First, we control for a large set of variables
capturing a newborn’s health at birth. We specifically choose variables such as sex and
plurality of births that are not easy to manipulate and observable to the hospital staff who
reports newborns’ weight. These are variables that may influence reported birth weight.
Second, we restrict our analysis to newborns who survive the first day of their life, thus
excluding those very fragile cases for whom hospital staff may expect an early death, mak-
ing upcoding of birth weight not worthwhile. In a third set of results, we further include
hospital fixed effects in our estimations, taking into account possible differences in coding
practices and treatment across hospitals.
Our findings show that without controls and not restricting to first day survivors
newborns with weight below almost all of the eight thresholds stay in the hospital longer,
receive more procedures, and have lower mortality (during the hospital stay). However,
for all but the highest two thresholds (2000g and 2500g) these results become insignificant
or even change sign, when we control for health at birth, exclude newborns who die on the
first day of life, and include hospital fixed effects. We interpret this as evidence that neither
reimbursement differences, nor the diagnostic threshold of 1500g or thresholds in medical
guidelines trigger additional care or reduce mortality among newborns in Germany. While
our results may indicate that newborns with weight just below 2000g and 2500g benefit
from being below these thresholds, we believe that the differences rather reflect systematic
upcoding related to factors that we cannot control perfectly. As further discussed in the
final section of this paper, we therefore conclude that DRG-related upcoding in Germany
does not affect the care upcoded newborns receive.
Our paper contributes to and brings together two strands of literature. The first fo-
cuses on the question whether hospitals upcode diagnoses or other health measures, such
as birth weight, to generate higher payments in DRG reimbursement systems. Concerning
the upcoding of diagnoses, Dafny (2005) shows that hospitals reacted to a recalibration
of Medicare DRGs in 1988 by disproportionally shifting patients to diagnoses codes that
became more lucrative. At the same time, she finds no changes in the treatment that
patients receive nor in patient mortality. Silverman and Skinner (2004) focus on Medi-
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care patients with respiratory disease and show that the share of patients coded to the
highest paying DRG increases significantly over time, particularly so in the group of for-
profit hospitals. Furthermore, there is evidence that also hospitals in the Italian region
of Emilia-Romagna (Verzulli et al. 2016), Portugal (Barros and Braun 2016) and Nor-
way (Januleviciute et al. 2016) upcode patients to the highest paying DRGs. Concerning
upcoding of patient characteristics, Shigeoka and Fushimi (2014) show that hospitals in
Japan have manipulated birth weight as a response to the introduction of a partial PPS
in a way that increased hospital payments. Similarly, Jürges and Köberlein (2015) find
that German hospitals reacted to the introduction of the DRG payment system in 2003
by systematically under-reporting newborns’ weight.
The second strand of literature focuses on the effect of birth weight thresholds on the
quantity and quality of care that newborns receive. Based on the census of U.S. births,
Almond et al. (2010, 2011) find that newborns with weight just below the very low birth
weight threshold at 1500g have higher survival chances than newborns with weight above.
Based on hospital discharge data for five states they further find that birth weight below
1500g triggers additional care that also results in higher hospital charges. Their results
are particularly concentrated among low quality hospitals, i.e., those hospitals that offer
no or only low levels of neonatal intensive care. Similar effects of the very low birth weight
thresholds have been found for newborns in Chile where medical guidelines explicitly re-
commend different treatment depending on a very low birth weight diagnosis (Bharadwaj
et al. 2013). Breining et al. (2015) focus on Denmark where the treatment recommend-
ations in medical guidelines only vary across the very low birth weight thresholds for
newborns with at least 32 weeks of gestation. They find that indeed only for newborns
born at 32 weeks of gestation or more, treatment depends on birth weight. For new-
borns born earlier in the pregnancy they find no treatment differences with birth weight,
indicating that medical guidelines have an impact on the care that newborns receive.
Our paper brings these two strands of the literature together in investigating whether
newborns benefit from upcoding of birth weight below thresholds that may themselves
affect the care that newborns receive as they are diagnostic thresholds. Our analysis
contributes to the first strand of the literature by investigating effects of upcoding on the
care the patients receive. We add to the second strand by focusing not only on the very
low birth weight threshold but also on other thresholds that impact diagnoses and appear
in medical guidelines.
The rest of the paper is structured as follows: In section 2, we give an overview on the
institutional background in Germany and discuss which different birth weight thresholds
may be related to the quantity and quality of care that newborns receive. We introduce
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our data in section 3 and the empirical strategy in section 4. In section 5, we present our
results, the sensitivity of which we explore in section 6. The paper closes with a discussion
and conclusion in section 7.
2 Institutional Background
In this section we give a brief overview on the German DRG (G-DRG) system and then
describe reasons why the treatment that newborns receive in German hospitals may vary
around birth weight thresholds.
2.1 The G-DRG reimbursement system
Until the year 2003, German acute care hospitals were reimbursed through a multiple-
source-system consisting of a hospital specific patient/day base-rate, a ward specific rate
and case-based lump-sums. In order to increase efficiency and, in particular, reduce length
of stay, the G-DRG system was introduced. Under the old and the new system, reimburse-
ment was and is generally the same irrespective of individuals’ insurance status (public
or private). Based on the Australian DRG system, 664 DRGs defined by combinations of
diagnoses, performed procedures, hours of ventilation, age and (for perinatal DRGs) birth
weight were set up. To each DRG a case-weight was assigned which determined the final
reimbursement. This case-weight multiplied by a base-rate gives the amount of money a
hospital receives for treating the respective patient.
In a transition period from 2003 to 2010 hospital specific base-rates were used. These
rates advanced towards state specific rates over the years.1 Since 2010 most hospitals are
reimbursed according to this state base-rate. From 2010 to 2014 these state specific base
rates in turn narrowed down to a federal base rate interval (Salm and Wübker 2015).
Case-weights and group definitions vary from year to year. The German Institute for
Hospital Reimbursement2 decides on changes of case-weights and DRG definitions every
year using information on actual costs of different treatments reported voluntarily by a
group of hospitals. Since the introduction of the G-DRG system, the number of DRGs
almost doubled to 1200 in 2015.3
1 The reason for starting with hospital specific rates was that hospital cost structures were drastically
different when the G-DRG system was introduced. Starting off directly with identical reimbursement in
each state would have led to major financial struggles for some hospitals.
2 Institut für das Entgeldsystem im Krankenhaus (InEK), financed by private and social health insurers
as well as the German Hospital Association.
3 For an analysis of these changes see Schreyögg et al. (2014).
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The change over time in the number of DRGs in neonatal care, however, was not as
drastic. When DRGs were first put into use in Germany in 2003, 38 different groups
for the treatment of newborns were defined. Until 2015 this number has increased only
slightly to 42 groups. The majority (37/42) of these groups depend on birth weight. The
remaining 5 DRGs are for newborns that die within the first four days of their life and
for specific cardiovascular conditions. The 37 birth-weight related DRGs depend on eight
birth weight thresholds. Within each birth weight interval multiple DRGs cover different
degrees of treatment complexity and complications. For our main analysis, we investigate
differences across these thresholds.
In order to compare only similar cases left and right of the thresholds we also conduct
analyses within “severity groups” across thresholds. To this end we group the DRGs into
six severity groups that have the same level of complications and complexity based on the
DRG catalog. Within each severity group birth weight should be the only difference across
thresholds. Table A.1 (in the Appendix) shows which DRGs we assign to the different
severity groups in the different birth weight intervals. Group 1 in Table A.1 comprises
the least severe cases, group 6 the most severe ones. At very low birth weights there are
only two different groups of severity. The first contains newborns with lower levels of
complications and less severe health conditions. This group splits up into four groups for
higher birth weight intervals (group 1-4). The second group contains more severe cases
and splits up into two groups for higher birth weights (group 5/6). Starting from a birth
weight of 1000g, three severity groups apply as the joint group 5 and 6 is split into two
severity groups. At birth weights of 1500g and higher all 6 groups are present.
2.2 Treatment and birth weight
Broadly speaking, there are two reasons for differences in treatment of newborns across
birth weight intervals. As explained in more detail below, the first is that DRGs are
defined along birth weight intervals, leading to sharp increases in reimbursement when
birth weight crosses from above to below thresholds and hence more funds to spend on
costly procedures. The second reason is that birth weight thresholds are used in the
diagnosis of newborns, define the level of specialization of the hospital that the newborn
should be treated in, and appear in medical guidelines.
Thresholds and reimbursement
Figure 1 provides a systematic overview on changes in case-weights with birth weight
within the six DRG severity groups defined above, i.e. holding everything else except for
birth weight constant. Generally, the case-weight decreases at 600g, 750g, 875g, 1000g,
1250g, 1500g, 2000g, and 2500g. Reimbursement for newborns with weight just below
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the thresholds is thus generally higher than for newborns with weight on or above the
thresholds. The sizes of the jumps in case-weights (and thus in reimbursement), however,
vary across groups and within groups across thresholds. The 2500g threshold for example
is not relevant for reimbursement for newborns in the least severe group (Group 1), while
the 750g threshold only hardly matters for the cases with most severe conditions (Group
5/6).
– FIGURE 1 ABOUT HERE –
As an example for how small changes in birth weight can affect reimbursement let’s
consider a notional hospital in the German state of Hesse in the year 2010 which had a
base-rate equal to the state base-rate of €2,968.56. A generic newborn in this hospital
may have had a birth weight of 1004g and was assigned DRG P63Z4 which in this year had
a case-weight of 8.776. Total reimbursement to the hospital would have been €26,052.08.
Had the weight instead been 999g, DRG P62D with a case-weight of 15.51 would have
been assigned. This means the hospital would have received €46,042.37, a plus of almost
€20,000 for a 5g change in birth weight.
As the financial incentives apply to the hospital, while treatment is typically decided
on by the medical personnel, one might argue that these reimbursement differences should
not play a large role for medical decision making. However, Jürges and Köberlein (2015)
have shown that reimbursement differences by birth weight have led to manipulation of
reported weight. As birth weight is reported by medical personnel, the individuals who
decide on treatment are aware of the financial importance of reimbursement differences.
If they are also informed about the costs of different procedures, they may also take these
differences in reimbursement into account when deciding on which treatment newborns
receive.
Thresholds and medical guidelines
In addition to reimbursement differences, birth weight determines the level of specializ-
ation of the hospital in which newborns should be treated. In Germany, four degrees of
specialization are defined by the Gemeinsamer Bundesausschuss (2013)5: Level 4 indicates
regular maternity clinics, Level 3 means that basic neonatal care can be provided, Level 2
4 For example, because it was a girl, ventilation was in use for 48 hours, respiratory distress syndrome
(ICD-10-GM: P28.5), systematic inflammatory response-syndrome (ICD-10-GM: R65.0), and some other
infectious disease (ICD-10-GM: P37.9) were diagnosed and the girl was treated by monitoring cardiovascu-
lar levels (OPS: 8-930), was given a VR-infusion (OPS: 8-811.0), CAPA ventilation was performed (OPS:
8-711.00) and after this did not work out, endotracheal intubation (OPS: 8-701) came into use.
5 The highest self administration unit in the German health sector which consists of 13 members
representing health insurers, providers as well as the general public.
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clinics have some specialization in neonatal care, and Level 1 clinics maintain neonatal in-
tensive care units (NICUs). Pre-term births with weight above 1500g should be treated in
clinics of at least Level 3, birth weight between 1250 and 1500g induces Level 2 care, while
newborns below 1250g should be treated in Level 1 clinics.6 7 To the extent that better
care is provided in more specialized hospitals, birth weight just below the thresholds that
require care in more specialized hospitals, in particular below 1250g could be beneficial
for newborns.
As results in the earlier literature suggest (Almond et al. 2010; Bharadwaj et al. 2013),
further differences in treatment around birth weight thresholds could result as a con-
sequence of thresholds in medical guidelines or as thresholds determine diagnoses, such as
the international standard classifications of extremely low (below 1000g), very low (below
1500g), and low birth weight (below 2500g). The German Association of the Scientific
Medical Societies (AMWF) publishes a multitude of medical guidelines for neonatal care.
They range from guidelines concerning the care of very frail newborns to care for healthy
newborns. Additionally, there are guidelines on after-hospital care for groups of newborns
with specific conditions. Except for the 875g and 2000g thresholds, all reimbursement rel-
evant thresholds are mentioned in at least one of the guidelines concerning neonatal care.
The threshold that appears most often is 1500g, the diagnostic threshold for very low birth
weight. Only few guidelines, however, give specific recommendations on care depending
on birth weight. One example that does is the guideline on parenteral nutrition. Among
other things, it recommends specific nutritional solutions for newborns with weight below
1500g (AWMF 2014). Most recommendations seem to be linked to gestational age rather
than weight.
Although they do not contain specific treatment recommendations, several guidelines
report risks of specific diseases or survival chances for birth weight intervals. For example,
the risks of complications like necrotizing enterocolitis (11% for 401-750g, 9% for 751-
1000g, 6% for 1001-1250g, and 4% for 1251-1500g) and patent ductus arteriosus (30% for
pre-term birth with weight below 1500g, and 50-70% for newborns below 1000g) are re-
ported for birth weight intervals. Furthermore, survival chances for esophageal atresia are
reported separately for newborns with weight above or below 1500g, with higher chances
6 Interestingly, the German Association for Perinatal Medicine uses different Level labels (1, 2a, 2b
and 3) and slightly different thresholds which would admit less newborns to NICUs (Bauer et al. 2006).
Nevertheless, the Gemeinsamer Bundesausschuss (2013) regulations are binding.
7 Theoretically this structure could offer an incentive for hospitals to increase birth weight of newborns
that would be too light for this type of clinic and would be transferred otherwise. Since case-weights are
calculated for average newborns within a birth weight bracket, reimbursement would most likely not cover
all the costs for newborns at the lower end of a birth weight DRG, making over-reporting of weight to
keep newborns implausible (Jürges and Köberlein 2015).
7
for heavier newborns (AWMF 2012). Although risk classifications are no direct recom-
mendations on care, they may result in treatment differences, to the extent that they
influence physicians’ awareness of risks for newborns in the different weight groups.
As some thresholds are only relevant for reimbursement (875g, 2000g), while others
affect reimbursement as well as the type of hospital that a newborn should be treated in
(1250g), or overlap with diagnostic thresholds and are mentioned in medical guidelines
(600g, 750g, 1000g, 1500g, 2500g), we can shed light on the importance of the drivers of
differences in medical care around the thresholds by comparing effects across thresholds.
3 Data
Our analyses are based on the universe of German hospital claims from the years 2005–
2011. All German hospitals have to submit their DRG claims to the Institute for Hospital
Reimbursement (InEK). InEK forwards parts of the data to the German Federal Statistical
Office, which makes the data available to researchers.8
For each of the roughly 20 million hospital stays per year in Germany, the data contain
basic demographic information on the patients, as well as detailed information on the
hospital stay. In addition to the exact DRG used for reimbursement, the data contain
information on the reason for the hospital stay, the length of the stay, procedures performed
during the stay (the German version of ICPM codes, called OPS codes), diagnoses (ICD-
10-GM) codes, and the reason of discharge (including regular discharge, death or referral
to a different hospitals among others). For newborns, the data further contain information
on birth weight.
In our analyses, we restrict the data to all births (cases with a perinatal DRG (those
beginning with “P”) and “birth” as cause of admission) with valid information on newborns’
sex and a birth weight between 450 and 3000g.9 After applying these selection criteria our
sample amounts to a total of 985,885 cases.
Table 1 displays basic descriptive statistics for our data, averaged across all cases
with birth weight 450-3000g and separately for the different birth weight intervals that
are relevant for reimbursement (< 600g, 600-749g, 750-874g, 875-999g, 1000-1249g, 1250-
1499g, 1500-1999g, 2000-2499g, 2500-3000g). It contains information on birth weight, on
quality and quantity of care (length of the hospital stay, number of procedures, mortality),
on the newborn’s health at birth, as well as hospital related control variables.
8 For further information on the data see www.forschungsdatenzentrum.de/en/database/drg.
9 By selecting only cases with “birth” as cause of admission, we exclude cases that are re-admitted
after a first discharge. Since patients cannot be linked across hospital stays, this is necessary to avoid
double-counting newborns that leave the hospital and are re-admitted later.
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– TABLE 1 ABOUT HERE –
On average, newborns have a birth weight of 2601g, have 2.6 reported procedures,
and stay in the hospital for 8.5 days. Only 0.6% of newborns die during the hospital
stay10. Birth weight increases mechanically across the birth weight intervals. At the same
time quantity of care and mortality generally decrease. The 600g threshold constitutes an
exception: Newborns with weight below 600g receive less care than newborns in the next
interval. This may be explained by the fact that in the lighter group of newborns a larger
share dies very early on (34% die on their first day of life, compared to 13% in the group
with weight 600-749g), likely leading to shorter hospital stays and fewer procedures for
the group with weight below 600g.
To measure health at birth we use variables that are visible at birth and known health
risk factors for newborns. These are important variables for our analysis as they could
influence the reporting of birth weight as well as the care that newborns receive in the
hospital. In addition to sex, pre-maturity, and plurality of birth (which are mentioned
explicitly as risk factors for newborns’ survival in medical guidelines (AWMF 2007)),
we focus on two conditions that usually become apparent during or right after delivery
and are leading causes of death among pre-term births: asphyxia and infant respiratory
distress syndrome (IRDS). Furthermore, we include several indicators for maternal health-
behavior during pregnancy, namely whether the mother smoked, drank alcohol, or took
illegal drugs.11
In our data, 44% of all newborns are boys12, 19% of births are premature, i.e., born
with at least 28, but less than 37 completed weeks of gestation (ICD-10-GM: P07.3).
Moreover 1.2% are extremely premature, i.e., have a gestational age of less than 28 weeks
(ICD-10-GM: P07.2). 11% of newborns are twins. 0.4% are higher order births.
Asphyxia is a form of oxygen deprivation that occurs during delivery. The ICD-10-
GM coding system contains three different diagnosis codes for asphyxia, one for newborns
with severe asphyxia and a 1-minute APGAR score13 of 0-3 (ICD-10-GM: P.21.0), one for
10 We derive the information on whether a newborn dies from the reason of discharge.
11 Unfortunately, linking the data on newborns to their mothers – who constitute a separate hospital
case – is impossible. Most procedures concerning delivery - except for those specifically undertaken for
the newborn – are billed as the mother’s case, not the newborn’s case. Thus, the data contain almost no
information on what happened during pregnancy or delivery. To the extent that this information determ-
ines the newborn’s reported weight and later treatment, this is valuable information that we unfortunately
do not have in the data. To account for this as best as we can, we proxy for mothers’ behavior during
pregnancy by relying on diagnoses that the newborn receives.
12 This unusually low number may result from the high share of male still-births among low birth weight
newborns. Still-births are not included in our data
13 The APGAR score was developed in the 1950s to summarize a newborn’s health. It measures
Appearance (skin color), Pulse (heart rate), Grimace (reflex irritability), Activity (muscle tone), and
Respiration.
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newborns with mild asphyxia and a 1-minute APGAR score of 4-7 (ICD-10-GM: P.21.1), as
well as asphyxia without additional classification of severity (ICD-10-GM: P.21.2). Among
all newborns in our data 2.1% had general asphyxia, 1.6% had mild asphyxia, and 0.5%
severe asphyxia. IRDS (ICD-10-GM: P22.-) is a lung malfunction which is common among
preterm births and begins shortly after birth. About 10.6% of all newborns in our data
suffer from IRDS.
Only 1.2% of newborns in our data are (suspected to be) affected by maternal use of
tobacco (ICD-10-GM: P04.2). This number is much lower than prevalences of smoking
during pregnancy as reported in other sources. Kuntz and Lampert (2016), for example,
report a prevalence of 12.1% for children born in Germany in the years 2003–2012 based
on survey data. As only severe cases of smoking during pregnancy may be apparent to
the hospital staff at the time of delivery, it is likely that only severe cases of smoking
are flagged in our data. To the extent that newborns diagnosed with suspected damage
due to maternal smoking are those for whom the medical personnel expects higher needs
of care during the hospital stay and thus may also manipulate the weight, the indicator
available to us flags the relevant cases. On average, there are less than 0.1% of newborns
for whom alcohol use (ICD-10-GM: P04.3) and 0.2% for whom drug use during pregnancy
(ICD-10-GM: P04.4) are reported. The shares are higher (0.1% for alcohol use and 0.3
to 0.5% for drug use) for lower birth weight intervals. Similar to maternal smoking, we
believe that conditions related to maternal alcohol or drug use are coded for severe cases
of use and thus flag relevant cases.
The third part of Table 1 shows three measures that capture information on the hospital
as well as the medical personnel that delivered the treatment. The first variable is an
indicator for whether a newborn was treated in an inpatient ward, defined as a department
of the hospital where the staff (doctors, nurses, and midwives) are self-employed rather
than employed by the hospital. Even if newborns are not treated in an inpatient ward,
care can be partly delivered by self-employed doctors or midwives. Whether a newborn
was treated by a self-employed (inpatient) physician or self-employed (inpatient) midwife
is captured by the second and third variables. Information on the place of treatment and
the doctors and midwives that delivered the treatment is important for our analysis as the
incentives for birth-weight manipulation are slightly smaller in inpatient wards and as it
is possible that treatment differs when delivered by inpatient doctors and midwives who
generally also oversee outpatient treatment of the patient. Overall, 9.5% of newborns are
treated exclusively in inpatient wards and by inpatient doctors; 7.1% received care from
inpatient midwives.14 Although inpatient wards and inpatient doctors and midwives are
14 As midwives are mainly present in the hospital during delivery (and delivery is billed on the mother
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allowed to treat all newborns irrespective of their birth weight, only few inpatient wards
are specialized in treating low birth weight newborns. As a consequence, treatment in
inpatient wards and by inpatient doctors is rare for newborns with birth weight below
1500g (less than 1% of cases). Even among newborns with weight between 1500g and
1999g only 1.5% are exclusively treated in inpatient wards, compared to 6.3% for those
with weight between 2000g and 2499g, and 11.3% in the highest birth weight interval in
our data (2500g-3000g).
– FIGURE 2 ABOUT HERE –
Figure 2 provides additional information on the distribution of birth weight in our
data. It contains birth weight frequencies pooled across the years 2005–2011. The eight
birth weight thresholds that determine DRGs are indicated by the vertical lines. Figure 2
shows statistically implausibly large increases in frequencies slightly below the thresholds,
especially at 1250g, 1500g, 2000g, and 2500g. These increases are in line with the findings
by Jürges and Köberlein (2015) and indicate that hospitals under-report birth weight.
4 Empirical strategy
We aim at investigating whether newborns benefit from having a (reported) birth weight
below birth weight thresholds defined by the DRG system, medical guidelines or a com-
bination thereof. We therefore document differences in quantity and quality of care com-
paring newborns with weight just below and just above the eight reimbursement relevant
thresholds in Germany. To this end we start by estimating mean differences in 25g weight
intervals above and below the thresholds. Quantity of care is measured by the length of
the hospital stay and the number of procedures that newborns receive. Quality of care is
measured by mortality (during the hospital stay). To exclude the possibility that differ-
ences across thresholds can be expected as birth weight is related to health and newborns
with lower weight may thus simply need more care even if the difference in weight is not
large, we also report results for four placebo thresholds that do not affect reimbursement
and do not appear in medical guidelines.
Earlier studies on differences in birth weight thresholds have relied on the assumption
that newborns left and right of the analyzed thresholds are similar in terms of health
(e.g. Almond et al. 2010; Bharadwaj et al. 2013; Breining et al. 2015). The thresholds
considered in these studies, however, were not relevant for reimbursement and thus did
not the newborn), fewer newborns are recorded as having been treated by inpatient midwives than are
treated solely in inpatient wards or receive treatment by inpatient doctors.
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not give hospitals a financial incentive to manipulate birth weight. As Figure 2 and
Jürges and Köberlein (2015) (with another data source) show, birth weight manipulation
is common in the German DRG system. The assumption that newborns left and right of
the thresholds are similar in terms of required care and expected outcomes could therefore
only hold if the manipulation of birth weight happened randomly, or at least independent
of the newborns’ health. Jürges and Köberlein (2015), to the contrary, suggest that
manipulation is systematic: there seems to be more under-reporting of birth weight for
newborns who are expected to need more care (those who are fragile but not likely to die
very early on).
Raw differences in quantity and quality of care around the birth weight thresholds
therefore do not constitute causal effects of having a weight below the threshold. To
investigate whether at least part of observed difference is likely causal, we proceed by
conducting parametric regressions, in which we subsequently add more control variables
that account for differences in the likelihood of birth weight manipulation and may explain
treatment differences. We implement the following parametric regression equation:
Yi = α + β1(bwi < T ) + f(bwi − T + 1) + γXi + ui , (1)
where Yi is an outcome measure for the quality or quantity of care for newborn i, bwi
is the (possibly manipulated) birth weight, and 1(bwi < T ) is an indicator for newborn
i having a birth weight below the threshold T . The parameter of interest is β, which
measures the difference in outcomes around the threshold. In our baseline regressions we
include a (centered) second-order birth weight polynomial f(bwi−T +1), fitted separately
on both sides of the threshold and use all observations in a 100g bandwidth of the birth
weight threshold. In robustness analyses, we vary the bandwidth as well as the order of
the included polynomial. In an additional robustness analysis, we exclude newborns in 10g
windows left and right of the thresholds – so called “donut regressions”, as Barreca et al.
(2011) have shown that the exclusion of newborns in small windows around the thresholds
may have an influence on the results.
In our baseline analysis, we estimate four different specifications for each outcome. In
the first, we estimate equation (1) using all observations with weight in the 100g bandwidth
and without control variables Xi. In the second, we include a vector of control variables,
Xi to capture observable differences in the newborns’ health at birth and hospital-level
controls. If we observed all factors that trigger birth weight manipulation, β̂ estimated
based on equation (1) including our control variables would measure the causal effect of
having a weight below the different thresholds on the quantity and quality provided. As,
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however, it is unlikely that we can account for all factors that hospital staff observes at the
time of birth, we conduct a third analysis in which we exclude all newborns who die on
their first day of their life. All newborns who die during their first four days of life receive
the same DRG irrespective of birth weight. There is thus no incentive to manipulate
the weight for newborns for whom death can be expected at the time when birth weight
is reported. Newborns who are expected to die are therefore likely over-represented just
above the weight thresholds. This may explain lower mortality as well as higher treatment
intensity below the thresholds. By excluding newborns who die during their first day of
life, we aim at excluding this type of selective upcoding as a reason for differences in care
around the thresholds.
In addition to selective upcoding of newborns, differences across hospitals are a pos-
sible driver of observed differences around thresholds: For example, it could be the case
that well-managed hospitals understand the financial incentives stemming from the DRG
system and thus manipulate birth weight, while at the same time they deliver good care.
Newborns with (reported) weight below the thresholds would then over-proportionally be
treated in hospitals with better care, which would result in average differences in outcomes
across thresholds. To exclude this explanation for differences, we include hospital fixed
effects in our fourth set of analyses. With the inclusion of hospital fixed effects, we make
sure that treatment differences arise within hospitals, not across hospitals.
We further investigate drivers of observed differences in care across thresholds by con-
ducting sub-group analyses splitting the sample into the different severity groups. To
the extent that the severity groups succeed in holding health constant across thresholds,
differences in received treatment and mortality across thresholds are likely driven by the
difference in reimbursement or medical guidelines across thresholds.
To separate reimbursement effects and effects of diagnostic thresholds or medical
guidelines, we compare effects across the different thresholds. There are two thresholds,
875g and 2000g that are neither diagnostic thresholds nor appear in any of the relevant
medical guidelines. Differences across these thresholds are thus likely driven by reimburse-
ment rather than by medical guidelines.
5 Results
– TABLE 2 ABOUT HERE –
Table 2 reports differences in means between groups of 25g intervals across the eight
reimbursement-relevant birth weight thresholds (600g, 750g, 875g, 1000g, 1250g, 1500g,
2000g, 2500g), as well as for four thresholds that play no role in reimbursement or medical
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guidelines (700g, 1300g, 2200g, 2700g). In general, newborns with weight just below the
relevant thresholds stay longer in the hospital and receive more procedures than their
neighbors with weight on the other side of the thresholds. With the exception of an
increase in mortality below 875g, the share of newborns who dies during the hospital stay
and on their first day of life is smaller below than above the thresholds. At the 600g and
875g threshold hardly any of the differences are significantly different from zero. At the
other thresholds most differences are significant.
At least part of the raw difference in length of stay and number of procedures, however,
is likely explained by the differences in weight around the thresholds: At all placebo
thresholds newborns below the threshold stay significantly longer in the hospital and
receive more procedures. Controlling for birth weight as in equation (1) is thus crucial
when analyzing differences in care around the thresholds.
Although differences in the quantity of care exist around placebo thresholds, there are
no differences in mortality.15 This contrasts with the significant decreases in mortality
across the reimbursement relevant thresholds (except at 875g). As first day mortality
varies even more strongly around the thresholds than overall mortality, a large part of the
difference may be driven by selective upcoding.
The mean differences in health-related controls across the thresholds present additional
evidence for selective upcoding. In particular at the highest threshold of 2500g, all vari-
ables except for extreme prematurity and maternal alcohol use indicate that newborns just
below the threshold are in worse health than newborns above. The newborns just below
are 3.1 percentage points more likely to be male, 3.3 percentage points more likely to be
born prematurely, 3.1 percentage points more like to be twins and 0.1 percentage points
more likely to be higher order births. They are more likely to have any type of asphyxia,
IRDS or a suspected damage due to maternal smoking or drug use. Only few of these
variables show significant differences around the placebo thresholds of 2200 or 2700g, and
if the differences are significant they are much smaller in size. This suggests that hospital
staff manipulates the weight of at risk newborns – possibly to cover the expected higher
costs of treatment. At the other thresholds, the differences in health-related controls are
not as drastic. However, they also point into the direction of selective upcoding in favor of
the more fragile newborns, highlighting the possibility that selective upcoding may explain
differences in treatment and mortality across thresholds.
– TABLE 3 ABOUT HERE –
15To the extent that lighter newborns have higher mortality risks ceteris paribus, the additional care
that the lighter newborns receive may be effective in decreasing these additional risks.
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Regression results to facilitate the interpretation of the raw differences in treatment
and mortality around thresholds are displayed in Table 3. The first row for each outcome
displays the estimated coefficient β̂ in equation (1) when only a second order polynomial in
birth weight is included as a control. For the higher birthweight thresholds, this pattern
can also be clearly seen by plotting average length of stay and performed procedures
around the thresholds (Figures 3 and 4).
– FIGURE 3 ABOUT HERE –
The second row in Table 3 adds the controls for health at birth and hospital-level
variables; the third row restricts the data to those newborns who survive their first day
of life. The fourth row additionally adds hospital fixed effects to restrict the analysis to
within hospital differences.
– FIGURE 4 ABOUT HERE –
In line with the comparison of mean differences across reimbursement-relevant and
placebo thresholds in Table 2, adding controls for birth weight already reduces the number
of significant differences in quantity of care. While in Table 2, 5 of 8 reimbursement-
relevant thresholds showed significant differences in length of stay, and 6 of 8 in the number
of procedures, only 4 of the 8 thresholds show significant differences when birth weight is
controlled for in Table 3. Similarly, the differences at the placebo thresholds are rendered
insignificant almost entirely when birth weight is controlled for. The inclusion of health-
related and hospital-related controls in row (2) reduces the coefficients for differences in
length of stay and number of procedures across the reimbursement-relevant thresholds
by almost half on average. The coefficients for the placebo thresholds remain almost
unchanged. When additionally restricting the analysis to first day survivors (row (3)),
the coefficients are further reduced towards zero and only 3 out of 8 remain significant
for length of stay and 4 of 8 for number of procedures. At least half of the difference
in treatment across thresholds thus seems to reflect selective upcoding. When we focus
at within hospital differences in row (4), only the differences across the highest weight
thresholds (2000g and 2500g) remain positive and significantly different form zero. The
differences around the other thresholds are not significant or sometimes even turn negative.
Within hospitals, there thus seems to be very little difference in treatment of at risk
newborns due to weight thresholds when observable health differences are controlled for.
Only for heavier newborns (for whom treatment may not be as decisive as the risk of
mortality is much lower) differences persist.
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The share of newborns who die during the hospital stay is significantly lower below
all but the 875g threshold when birth weight is included as control as can be seen in the
first row of the mortality results presented in Table 3. The inclusion of health-related and
hospital control variables shrinks some coefficients slightly towards zero but the differences
at most thresholds remain statistically significantly different from zero. As row (3) of the
results indicates, however, the observable differences in mortality are largely driven by first
day mortality. When newborns who die on their first day of life are excluded from our
data, only the differences at 750g and 2000g remain negative and statistically significantly
different from zero. To the extent that medical personnel expects the early death of
newborns who die during their first day of life and thus do not upcode their birth weight,
these results suggest that selective upcoding of newborns drives almost all of the observed
differences in mortality. These results remain almost unchanged when hospital fixed effects
are included (row 4). Differences across hospitals thus do not seem to play a big role.
– TABLE 4 ABOUT HERE –
Table 4 displays the β̂s estimated for the different severity groups including polynomials
in birth weight as well as all control variables and hospital fixed effects and excluding those
newborns who die on their first day of life from the data. The results indicate that the
differences in quantity of care observed for the higher thresholds (2000g and 2500g) in
Table 3 are concentrated in severity groups 1 and 2, i.e., those newborns with the least
complications and lowest level of severity. The differences within the higher severity groups
are not statistically significant, which may, however, also reflect smaller sample sizes for
the higher severity groups. Table 4 additionally shows significant differences in quantity
of care for the severity groups around the 1000g threshold. At the same time, mortality
is higher below the 1000g threshold in these severity groups. The reason for this is most
likely that hospitals do get extra reimbursement for long ventilation hours if newborns are
heavier than 1000g. Here, hospitals have an incentive not to upcode newborns that have
a high survival probability with long expected ventilation hours.
Concerning the question whether reimbursement relevant thresholds alone trigger ad-
ditional care for newborns with weight below the threshold, we look at the results for
the 875g and 2000g thresholds that affect reimbursement but are not part of medical
guidelines. For 875g, none of the differences are significantly different from zero – not
even the raw differences in Table 2. For 2000g, some differences are significant and remain
significant even in the specifications that take selective upcoding and differences across
hospitals as well as (ex post) health severity into account in the subgroup analyses. How-
ever, there are no differences for the more severe cases in severity groups 4 to 6. While we
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thus cannot exclude that newborns with weight below the 2000g threshold receive some
additional care due to the increase in reimbursement, this effect seems to be concentrated
to newborns with the best health, suggesting that among those newborns who require
care it is delivered independent of their weight. Furthermore, the results for the 1500g
threshold – the reimbursement relevant threshold that is at the same time a diagnostic
threshold and that appears most often in medical guidelines – indicates that adding the
financial incentives to the possible medical indication to additionally treat newborns with
weight below this threshold has likely no detrimental effect on newborns with weight above
the threshold.
Overall, the results presented in this section show that the differences in treatment
across birth weight thresholds are mainly driven by selective upcoding as are differences
in mortality. Differences in treatment, however, remain across the diagnostic threshold for
extremely low birth weight (1000g) as well as for relatively healthy and heavy newborns
(severity groups 1 and 2 at 1500g, 2000g, and 2500g). The additional quantity of treatment
does not seem to result in higher survival rates. It may - of course - have other health
benefits for the newborns later on in life; an outcome that we cannot observe in our data.
6 Sensitivity Analyses
In this section we present results of three sets of sensitivity analyses. First, we explore the
sensitivity of the results to a so-called donut-regression and thus to excluding from our
data newborns with weight very close to the thresholds. Second, we explore whether the
choice of the polynomial in birth weight affects the results, and third whether the choice
of bandwidth has an impact.
– TABLE 5 ABOUT HERE –
All results presented in Table 5 are variations of the most comprehensive specification
presented in Table 3 including controls for birth weight, health-related as well as hospital-
related control variables, hospital fixed effects and excluding newborns who die on their
first day of life.
The results of the donut regressions are presented in the first rows of results for each of
the three outcomes (length of stay, number of procedures, and mortality). Compared to
the main results in Table 3, excluding newborns in a 10g interval around each threshold
induces only minor changes for the quantity of care but renders the mortality results
insignificant and even turns around some of the signs. For length of stay, the previously
significantly negative coefficients at the 600g and 1500g thresholds become insignificant
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when newborns with weight in a 10g interval at each side of the respective thresholds are
excluded, while the positive coefficients at 2000g and 2500g even increase in value and stay
significantly different from zero. The estimates for the number of procedures are hardly
affected at all by the exclusion of the donuts in birth weight. In terms of mortality, the only
coefficient that was significant in the main results at 2000g becomes insignificant when the
donut is excluded. At the same time, differences at 1000g and 1500g become significantly
positive. Overall, excluding the donut around the thresholds thus supports the conclusion
that differences in treatment exists if at all only at the highest weight thresholds and that
these differences do not affect mortality.
The second and third rows for each outcome in Table 5 report the results with different
orders of the polynomial in birth weight. While we use a second order polynomial in the
main specification displayed in Table 3, the results in row (2) of Table 5 are based on a
linear fit and the results in row (3) on a third order polynomial. While there are slight
changes in the estimates of the differences across thresholds, changing the order of the
polynomial has in general only limited effects on our results. The results for the highest
threshold (2500g) are particularly stable, indicating that – irrespective of the order of
the polynomial included – newborns with weight below the threshold receive significantly
more care than newborns above, while there are no differences in mortality. The results
for the next highest threshold (2000g) are also very stable for mortality suggesting reduced
mortality below the threshold. The differences in the quantity of care, however, become
insignificant with a third order polynomial. For the lower thresholds, there are hardly any
significant differences in any of the outcomes irrespective of the order of the polynomial
included.
The fourth and fifth rows for each outcome in Table 5 report results when changing
the bandwidth. The main results are based on a 100g bandwidth. Row (4) in Table 5
reports results for a 50g bandwidth, row (5) using the entire birth weight interval, e.g.
450-599g below 600g, and 600-749g above 600.16 Again, there are only minor changes in
the coefficient estimate of interest due to the changes in bandwidth. Similar to the other
sensitivity analyses, the results are extremely robust for the highest threshold (2500g).
But also at the lower thresholds, only minor changes occur.
Overall, the results presented in Table 5 highlight that our results are not driven
by newborns that have weights very close to the thresholds, nor by the choice of the
order of the polynomial in birth weight or by bandwidth choice. All sensitivity analyses
indicate that – despite controlling for an extensive set of variables related to health and
16For the placebo thresholds, we use all observations in the interval between the reimbursement relevant
thresholds in which the placebo threshold lies. E.g. for the threshold of 700g, we use 600–749g, and for
1300g, we use 1250–1499g.
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the place as well as the people who deliver the care, hospital fixed effects and excluding
newborns who die very early on – newborns below the highest weight threshold receive
more care than their immediate neighbors with weight at or above the threshold. The
results for differences in care around the next highest threshold (2000g) are somewhat
more sensitive to the exact specification but also indicate overall that newborns below the
threshold receive additional care. For these groups of newborns, mortality differences are
also observed in most specifications. For all lower thresholds, hardly any of the differences
are significantly different from zero – irrespective of the specification.
7 Discussion and Conclusion
In this paper, we investigate whether birth weight thresholds in hospital reimbursement
systems affect the quantity and quality of care delivered to newborns. Using the universe
of hospital births in Germany from the years 2005–2011, we document that newborns
with weight below all but one reimbursement relevant threshold receive more care and
have lower risk of dying during the hospital stay than their neighbors with weight at or
above the respective thresholds. For all but the highest weight threshold (2500g) the
differences in care around thresholds, however, do not remain significant when controlling
for birth weight and differences in health around the thresholds that are observable to
us as researchers and also to the medical personell that reports birth weight. The health
differences therefore likely result from selective birth weight manipulation as medical staff
in hospitals tends to under-report a newborn’s weight if higher costs are expected. Overall,
our results suggest that – if at all – only the heaviest newborns (in our sample with birth
weight just below 2000g or 2500g) and among those the group with the least severe health
conditions as measured by the assigned DRG stay longer in the hospital and receive more
procedures because their weight is below the threshold.
These results lead to the questions what drives the differences in care around 2000g
and 2500g and why there are no (robust) differences around the other thresholds. A likely
explanation is that we do not account for selective upcoding well enough for the higher
threshold. The differences in care for the lower thresholds mainly disappear when the
analyses are restricted to first day survivors. As mortality and first day mortality decrease
with weight, whether newborns are expected to survive or not is likely not the margin
that determines upcoding for higher weight newborns. Instead, other measures such as
gestational age may be more important. Jürges and Köberlein (2015) for example find
that newborns in the 25g weight interval below the 2500g threshold have on average almost
four fewer days of gestational age compared to newborns with weight of 2500-2525g. As in
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our data we only observe broad categories of gestational age, we cannot fully control for
these differences. While for the lower weight groups this may not matter as differences in
gestational age translate into early mortality (which we observe and control for), this is not
necessarily the case for the high weight thresholds. To us, the most plausible explanation
for the remaining differences in quantity of care around the higher weight thresholds is
that we cannot fully control for selective upcoding.
Of course, the differences in care around the higher thresholds could also reflect actual
differences, e.g. triggered by the additional reimbursement or the fact that newborns
with weight below 2500g receive a diagnosis of low birth weight, which may possibly
increase the attention of hospital staff. However, it is unclear why similar differences
should not be observed for the lower weight thresholds, specifically as the latter also trigger
diagnoses (e.g. 1500g and 1000g) and result in much larger differences in reimbursement
for the hospital. Overall, we thus judge it to be more likely that neither reimbursement
differences nor medical guidelines or diagnostic thresholds induce differences in neonatal
care in German hospitals.
In light of the evidence from other countries concerning the benefits of having a birth
weight just below 1500g and as reimbursement differences should if at all only add to the
existing differences caused by the diagnostic threshold, these result may seem surprising.
However, Almond et al. (2010) show that the differences in neonatal mortality and care are
not present in all hospitals. Instead the effects are driven by low quality ones. Furthermore,
medical guidelines in Germany give only very few recommendations that depend on birth
weight, which may explain differences compared to other countries like Chile and Denmark
where explicit recommendations with respect to birth weight exist (Bharadwaj et al. 2013;
Breining et al. 2015). Last but not least, like in the other studies on upcoding (Dafny 2005;
Verzulli et al. 2016), higher reimbursement only depends on the reporting of characteristics
or diagnoses – in this case birth weight – not on the treatment that is delivered. Our
findings of little changes in quantity and quality of care thus align with the earlier findings
that additional resources acquired through upcoding do not profit the specific patients
whose records are manipulated.
To conclude, we interpret our results in a way that financial incentives relating to
birth weight in Germany do lead to birth weight manipulation but do not directly impact
the care that specific newborns receive. This suggests that hospital staff is willing to
manipulate records according to their employers’ financial incentives but does not take the
implications of these incentives (higher funds available for the specific case) into account
when making critical medical decisions. This finding is in line with physicians taking
treatment decisions in the interest of their patients.
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Tables and Figures
Table 1: Summary statistics, by birth weight bracket, 2005-2011
<600 600-749 750-874 875-999 1000-1249 1250-1499 1500-1999 2000-2499 2500-3000 All births
Birth weight (gram) 527.092 680.801 816.950 948.530 1149.752 1404.486 1808.097 2306.875 2808.359 2601.265
(43.828) (45.427) (34.144) (37.177) (69.413) (72.487) (134.898) (136.260) (140.054) (441.940)
Outcomes
Length of stay (days) 53.706 69.951 67.946 61.468 50.428 39.012 23.776 9.821 4.662 8.452
(62.826) (55.507) (43.185) (34.718) (27.785) (21.412) (16.439) (9.564) (4.196) (14.196)
Procedures (#) 11.729 14.354 13.638 12.192 10.203 8.296 5.942 3.208 1.724 2.559
(11.393) (10.688) (9.407) (7.569) (6.662) (5.129) (4.154) (2.988) (1.601) (3.275)
Mortality .487 .236 .126 .069 .042 .025 .012 .003 .001 .006
(.500) (.425) (.332) (.253) (.201) (.155) (.111) (.057) (.028) (.077)
First-day-mortality .339 .125 .056 .031 .024 .014 .008 .002 .000 .003
(.474) (.331) (.231) (.174) (.154) (.118) (.087) (.044) (.021) (.059)
Health-related controls
Male births .474 .502 .521 .529 .518 .501 .484 .453 .432 .442
(.499) (.500) (.500) (.499) (.500) (.500) (.500) (.498) (.495) (.497)
Extreme prematurity .590 .581 .495 .369 .146 .037 .010 .003 .001 .012
(.492) (.493) (.500) (.483) (.353) (.188) (.102) (.055) (.025) (.107)
Prematurity .158 .198 .261 .364 .527 .611 .592 .350 .108 .188
(.364) (.399) (.439) (.481) (.499) (.488) (.491) (.477) (.311) (.391)
Twin birth .172 .173 .186 .211 .229 .260 .303 .229 .058 .107
(.378) (.378) (.389) (.408) (.420) (.439) (.459) (.420) (.235) (.309)
Multiple birth .022 .026 .026 .031 .043 .046 .026 .004 .000 .004
(.145) (.158) (.158) (.172) (.203) (.208) (.159) (.059) (.012) (.060)
continued on next page
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Table 1: Summary statistics, by birth weight bracket, 2005-2011 (continued)
<600 600-749 750-874 875-999 1000-1249 1250-1499 1500-1999 2000-2499 2500-3000 All births
Health-related controls (continued)
Asphyxia .127 .130 .125 .103 .096 .080 .056 .029 .013 .021
(.333) (.336) (.331) (.304) (.295) (.272) (.229) (.169) (.112) (.145)
Severe asphyxia .065 .055 .051 .036 .029 .022 .013 .006 .003 .005
(.247) (.228) (.220) (.187) (.168) (.145) (.115) (.079) (.050) (.071)
Moderate asphyxia .059 .074 .072 .065 .065 .057 .041 .022 .010 .016
(.235) (.262) (.258) (.246) (.246) (.233) (.198) (.147) (.098) (.124)
IRDS .622 .784 .799 .790 .717 .611 .399 .160 .040 .106
(.485) (.412) (.401) (.408) (.451) (.487) (.490) (.367) (.196) (.308)
Maternal smoking .013 .019 .023 .029 .027 .030 .037 .027 .006 .012
(.112) (.136) (.150) (.167) (.161) (.170) (.189) (.163) (.076) (.108)
Maternal alcohol use XXX .001 .001 .001 .001 .001 .001 .001 .000 .000
XXX (.036) (.038) (.034) (.032) (.037) (.038) (.028) (.013) (.019)
Maternal drug use XXX .002 .003 .003 .003 .005 .005 .004 .001 .002
XXX (.039) (.056) (.052) (.054) (.069) (.074) (.064) (.038) (.047)
Hospital-related controls
In-patient ward .007 .005 .006 .005 .004 .007 .015 .063 .113 .095
(.085) (.067) (.079) (.071) (.065) (.082) (.121) (.244) (.316) (.293)
In-patient midwife .016 .014 .014 .011 .014 .014 .022 .051 .082 .071
(.124) (.118) (.117) (.103) (.116) (.118) (.145) (.219) (.274) (.256)
In-patient doctor .007 .006 .007 .005 .005 .007 .015 .063 .113 .095
(.081) (.076) (.083) (.071) (.072) (.083) (.122) (.243) (.316) (.293)
Number of births 3059 4589 3461 5135 9698 15044 49708 167624 727567 985885
Notes: Standard deviations (in parenthesis) below means. Variable definitions: Procedures: Number of stated OPS codes (= German modification
of ICPM); Mortality: Infant death during hospital stay; First-day-mortality: Infant death on first-day of live in hospital; Extreme prematurity: Birth
with gestational age <28 weeks (ICD-10-GM: P07.2); Prematurity: Birth with gestational age >28 and < 37 weeks (ICD-10-GM: P07.3); Twin
birth: (ICD-10-GM: Z38.3); Multiple birth: (ICD-10-GM: Z38.6); Severe asphyxia: Asphyxia with APGAR score below 4 (ICD-10-GM: P21.0);
Moderate asphyxia: Asphyxia with APGAR score above 3 and below 8 (ICD-10-GM: P21.1); Asphyxia: Any asphyxia (ICD-10-GM: P21.x); IRDS:
Infant respiratory distress syndrome (ICD-10-GM: P22.0-P22.9); Maternal smoking (ICD-10-GM: P04.2), alcohol use (ICD-10-GM: P04.3), or drug
use (ICD-10-GM: P04.4): Newborn has been harmed by respective maternal behaviour; In-patient ward: Birth place is in-patient ward; In-patient
midwife: Birth with external midwife; In-patient doctor: Birth with external surgeon. Source: Own calculations based on the DRG-Statistic.
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Table 2: Differences above and below threshold, 2005-2011
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Outcomes
Length of stay (days) 3.187 11.364*** 2.338 8.629*** 2.099 3.135*** 4.024*** 1.602*** 5.589* 2.582** .758*** .165***
(3.378) (2.666) (1.983) (1.952) (1.289) (1.213) (.282) (.078) (3.077) (1.064) (.184) (.039)
Procedures (#) .606 1.142** .656 1.75*** .877*** .618** 1.042*** .737*** .982* .058 .208*** .049***
(.611) (.579) (.428) (.444) (.263) (.3) (.079) (.028) (.567) (.269) (.059) (.015)
Mortality -.022 -.088*** .03** -.033** -.015* -.041*** -.007*** 0 .008 -.009 0 0
(.027) (.022) (.015) (.016) (.009) (.01) (.002) (0) (.022) (.008) (.001) (0)
First-day-mortality -.041* -.065*** .011 -.05*** -.015** -.043*** -.004** -.001* .014 -.001 0 0
(.023) (.016) (.01) (.015) (.007) (.01) (.002) (0) (.016) (.007) (.001) (0)
Health-related controls
Male births .004 -.039 -.01 .021 -.003 .029 .021** .031*** .041 -.035 .007 .002
(.028) (.028) (.026) (.029) (.022) (.023) (.01) (.005) (.026) (.023) (.009) (.004)
Extreme Prematurity .014 .032 .041 .085*** .01 -.006 0 0 .004 .012 0 0
(.028) (.028) (.026) (.025) (.011) (.007) (.002) (.001) (.026) (.012) (.001) (0)
Prematurity .001 .021 -.003 .012 -.006 .024 .099*** .033*** -.006 -.043* .013 .019***
(.022) (.023) (.024) (.029) (.022) (.023) (.01) (.005) (.021) (.023) (.009) (.003)
Twin births -.004 -.015 -.047** -.024 -.007 .003 .001 .031*** .019 .015 .006 .015***
(.021) (.022) (.022) (.024) (.019) (.02) (.01) (.004) (.02) (.02) (.008) (.002)
Multiple births -.005 .008 -.011 -.022* -.004 -.003 .002 .001*** -.011 .003 .003* 0
(.008) (.009) (.008) (.013) (.01) (.009) (.002) (0) (.008) (.01) (.001) (0)
continued on next page
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Table 2: Differences above and below threshold, 2005-2011 (continued)
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Health-related controls (continued)
Asphyxia .033* .008 -.006 -.004 .001 .018* .002 .011*** .031* -.03** 0 0
(.02) (.018) (.016) (.017) (.013) (.011) (.005) (.002) (.018) (.012) (.003) (.001)
Severe asphyxia .019 -.013 .005 .003 0 .003 -.002 .002* .01 -.011 .001 0
(.014) (.013) (.011) (.01) (.007) (.006) (.002) (.001) (.012) (.007) (.001) (0)
Moderate asphyxia .011 .024* -.012 -.003 .004 .018** .003 .009*** .023 -.023** -.001 0
(.015) (.014) (.013) (.014) (.011) (.009) (.004) (.001) (.014) (.01) (.003) (.001)
IRDS .046* .061*** .006 .097*** .024 .119*** .111*** .081*** -.013 .009 .01 .005**
(.025) (.023) (.021) (.027) (.021) (.023) (.009) (.003) (.021) (.022) (.007) (.002)
Maternal smoking -.006 .005 -.001 .009 .003 .018*** -.001 .007*** -.005 -.002 .001 .002***
(.008) (.007) (.009) (.009) (.007) (.006) (.004) (.001) (.008) (.007) (.003) (.001)
Maternal alcohol use 0 -.004 .001 .002** -.002 0 0 0 -.001 .002 -.001 0
(0) (.003) (.002) (.001) (.002) (.002) (.001) (0) (.001) (.002) (0) (0)
Maternal drug use -.002 -.001 .004 0 -.004 0 .002 .003*** 0 -.002 .002 0
(.002) (.002) (.003) (.003) (.003) (.003) (.001) (.001) (.002) (.003) (.001) (0)
Hospital-related controls
In-patient ward -.001 -.01* -.006 -.003 -.006* -.013** -.024*** -.029*** .001 0 -.008** -.007**
(.005) (.006) (.004) (.005) (.004) (.006) (.004) (.003) (.003) (.003) (.004) (.003)
In-patient midwife -.005 -.009 -.009 -.007 -.006 -.001 -.014*** -.019*** .004 -.004 0 -.002
(.006) (.007) (.007) (.007) (.006) (.006) (.004) (.003) (.006) (.004) (.003) (.002)
In-patient doctor .002 -.002 -.008 .002 .002 -.016** -.022*** -.03*** .003 -.002 -.008** -.005*
(.004) (.004) (.005) (.003) (.003) (.006) (.004) (.003) (.004) (.003) (.004) (.003)
NL 587 1105 880 1881 1957 3881 5665 14432 635 731 5045 20825
NR 666 446 629 347 693 538 3806 19384 844 1348 8777 37094
Notes: Difference between means below and above birth weight threshold T within a ±25 gram bandwidth (X̄below-X̄above). (Robust) Standard errors in parentheses below
mean difference. NL: Number of observations left/below threshold within 25 gram bandwidth. NR: Number of observations right/above threshold within 25 gram bandwidth.
*** p<0.01; ** p<0.05 and * p<0.1. For variable definitions see table 1. Source: Own calculations based on the DRG-Statistic.
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Table 3: Regression estimates, 2005-2011
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Length of stay (days)
(1) 7.963 13.542*** 2.055 11.249*** 2.604 2.266 4.334*** 1.733*** 5.353 2.973* .244 .039
(5.141) (3.9) (2.986) (2.757) (1.893) (1.745) (.415) (.126) (4.441) (1.574) (.297) (.062)
(2) 2.821 8.778** 1.117 7.584*** 2.8 .677 2.753*** .911*** 5.869 2.83* .155 -.009
(4.636) (3.598) (2.726) (2.454) (1.777) (1.682) (.393) (.117) (4.245) (1.48) (.276) (.058)
(3) -2.824 5.149 1.876 5.452** 1.722 -.899 2.707*** .898*** 6.218 2.653* .153 -.009
(5.507) (3.684) (2.703) (2.49) (1.779) (1.736) (.394) (.117) (4.362) (1.464) (.276) (.058)
(4) -9.439* 4.206 -.078 -.457 -.883 -3.446* 1.451*** .834*** 5.877 2.79** -.053 .014
(5.389) (3.567) (2.465) (2.156) (1.746) (1.774) (.367) (.113) (4.132) (1.322) (.258) (.057)
Procedures (#)
(1) 1.407 1.427* .647 1.959*** 1.049*** .246 1.122*** .859*** 1.003 -.296 .164* .011
(.945) (.78) (.689) (.55) (.382) (.455) (.123) (.045) (.912) (.394) (.091) (.024)
(2) .234 .559 .486 1.16** 1.02*** -.225 .61*** .449*** 1.01 -.171 .135* -.014
(.822) (.708) (.64) (.487) (.354) (.436) (.112) (.039) (.851) (.368) (.081) (.021)
(3) -.544 -.056 .566 .87* .899** -.487 .605*** .448*** .843 -.186 .132 -.015
(1.006) (.758) (.656) (.512) (.363) (.456) (.112) (.039) (.92) (.371) (.081) (.021)
(4) -.596 -.221 .44 -.121 .508 -.569 .354*** .397*** 1.145 -.083 .112 -.024
(.964) (.707) (.591) (.475) (.339) (.455) (.105) (.036) (.82) (.336) (.075) (.019)
Mortality
(1) -.086** -.134*** .008 -.042* -.032** -.059*** -.011*** -.002** -.038 -.016 0 0
(.041) (.031) (.022) (.023) (.014) (.015) (.003) (.001) (.033) (.012) (.002) (0)
(2) -.06 -.108*** .009 -.036 -.03** -.056*** -.01*** -.002** -.046 -.016 0 0
(.038) (.03) (.022) (.023) (.014) (.015) (.003) (.001) (.032) (.012) (.002) (0)
(3) .015 -.044* -.002 .026** -.004 0 -.005*** 0 -.04 -.01 0 0
(.038) (.025) (.018) (.012) (.008) (.007) (.002) (.001) (.028) (.008) (.001) (0)
(4) .024 -.031 0 .017 .002 -.001 -.005** 0 -.046 -.012 .001 0
(.04) (.026) (.018) (.014) (.008) (.007) (.002) (.001) (.03) (.008) (.001) (0)
Number of births
(1)+(2)+(3) - NL 2002 3326 3015 4506 5264 8728 16919 57475 2639 4717 23288 99190
NR 2639 2581 3254 2470 3781 3938 15667 71505 2990 4892 30853 131754
(4) - NL 1333 3017 2871 4366 5166 8642 16833 57397 2198 4626 23222 99129
NR 2198 2424 3140 2388 3697 3867 15604 71449 2773 4803 30792 131682
Notes: Parametric regressions within ±100 gram intervals around birth weight thresholds. Coefficient of binary variable indicating observations below threshold.
(Robust) Standard errors in parentheses. NL: Number of observations left to/below the threshold . NR: Number of observations right to/above the threshold. All
regressions include a second order birth weight polynomial (fitted separately on each side of the threshold). Control variables are gender, (extreme) prematurity,
multiples, asphyxia, IRDS, in-patient ward/midwife/doctor, maternal smoking/alcohol consumption/ drug use and years. [Specification] (1) includes only the
binary birth weight threshold indicator variable . (2) additionally includes controls. (3) additionally restricts the sample to first-day-survivors. (4) additionally
includes hospital-fixed effects. *** p<0.01; ** p<0.05 and * p<0.1. For variable definitions see table 1. Source:. Own calculations based on the DRG-Statistic.
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Table 4: Regression estimates by Severity groups for first-day-survivors, 2005-2011
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Length of stay (days)
Severity group 1 8.398* 1.592*** .186*** .097 .045*
(4.679) (.43) (.046) (.16) (.027)
Severity group 2 4.086*** 1.287*** 1.162*** -.012 .122
-4.432 5.056 .323 12.425*** -.522 (1.196) (.336) (.174) -2.688 .396 (.257) (.141)
Severity group 3 (6.235) (3.454) (2.499) (3.503) (1.264) -.713 1.125* .642 (4.113) (1.275) .206 .724**
(1.362) (.618) (.418) (.611) (.367)
Severity group 4 -8.507*** 1.232 -.495 -.646 1.828
(2.941) (1.352) (1.212) (1.484) (1.296)
Severity group 5 12.98** -7.318** -26.351 -1.261 .235 8.823*** -4.425 -4.647
-12.335 3.665 -.964 (5.892) (3.289) (18.792) (3.652) (4.099) 7.472 (3) (4.388) (3.774)
Severity group 6 (9.098) (7.322) (6.782) 12.206** -5.219 -1.316 2.23 3.072 (7.939) 5.08 -3.022 -8.268*
(4.986) (3.938) (5.506) (4.894) (7.599) (3.125) (6.469) (4.734)
Procedures (#)
Severity group 1 3.001** .514*** .06*** .019 .001
(1.209) (.093) (.012) (.033) (.007)
Severity group 2 1.24*** .271*** .276*** .084 .027
.239 .381 .171 2.077*** .417 (.236) (.073) (.049) -.78 -.21 (.057) (.048)
Severity group 3 (.748) (.55) (.437) (.598) (.271) -.403 .133 .503*** (.571) (.275) .139 .093
(.293) (.153) (.117) (.151) (.108)
Severity group 4 -1.509*** .229 -.123 .309 .41
(.468) (.328) (.383) (.335) (.423)
Severity group 5 7.874*** -.25 -3.24 -.428 -1.672 .433 1.821 -.722
-2.143 -.976 1.064 (1.265) (.667) (3.717) (1.108) (1.521) 2.678* (.69) (1.275) (1.577)
Severity group 6 (1.78) (1.49) (1.808) 5.153*** .188 .277 -.327 .117 (1.554) .996 .292 -5.389***
(1.122) (.708) (1.676) (1.37) (1.888) (.82) (2.576) (1.809)
Mortality
Severity group 1 -.001 0 0 0 0
(.002) (0) (0) (0) (0)
Severity group 2 0 0 0 0 0
.034 -.028 -.015 .011 .002 (.001) (0) (0) -.018 -.003 (0) (0)
Severity group 3 (.049) (.028) (.019) (.022) (.004) -.002 0 0 (.035) (.003) 0 0
(.003) (0) (0) (0) (0)
Severity group 4 -.002 .004 -.023** -.004 0
(.003) (.005) (.01) (.003) (.003)
Severity group 5 .197*** .002 .008 0 .018 -.002 -.001 0
.046 -.074 .009 (.042) (.009) (.015) (0) (.015) -.029 (.023) (.007) (0)
Severity group 6 (.07) (.055) (.054) .158*** -.007 .039* -.043 .047 (.057) -.022 -.063 .011
(.037) (.019) (.021) (.052) (.04) (.019) (.044) (.018)
Number of births
1 - NL 5400 1337 33587 6115 76359
NR 34 3211 51886 11585 107440
2 - NL 5400 6902 13677 9036 12098
NR 785 2030 2111 3536 2061 1021 6305 10332 1354 2025 10613 13249
3 - NL 1354 1734 2525 650 1844 5400 3829 4754 1930 2536 3674 5591
NR 1046 2736 4897 3993 5651
4 - NL 5400 1590 1560 1326 1342
NR 618 1001 1155 1334 1321
continued on next page
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Table 4: Regression estimates for first-day-survivors by Severity groups, 2005-2011 (continued)
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
5 - NL 961 799 984 383 253 688 247 167
NR 627 1154 833 359 525 212 203 142 947 656 220 143
6 - NL 947 754 738 961 1114 1176 662 298 983 953 226 223
NR 553 694 298 187 192 875 252 234
Notes: Parametric regressions within ±100 gram intervals around birth weight thresholds by Severity group for first-day-survivors. Coefficient of binary variable indicating
observations below threshold. (Robust) Standard errors in parentheses. NL: Number of observations left to/below the threshold . NR: Number of observations right
to/above the threshold. Control variables include a second order birth weight polynomial (fitted separately on each side of the threshold), hospital-fixed-effects and dummy
variables for: gender, (extreme) prematurity, multiples, asphyxia, IRDS, in-patient ward/midwife/doctor, maternal smoking/alcohol consumption/ drug use and years. ***
p<0.01; ** p<0.05 and * p<0.1. For variable definitions see table 1. Source:. Own calculations based on the DRG-Statistic.
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Table 5: Regression estimates - Robustness, 2005-2011
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Length of stay (days)
(1) -13.927 4.157 -2.075 2.877 -1.965 -1.722 2.941*** 1.05*** 5.905 3.982* .328 -.044
(9.022) (5.9) (3.987) (3.458) (2.247) (1.873) (.627) (.155) (7.966) (2.209) (.402) (.089)
(2) -4.953 .591 .26 -1.645 -.796 -.716 1.034*** .648*** 5.858** 1.024 .072 .028
(3.532) (2.264) (1.659) (1.404) (1.083) (.993) (.25) (.069) (2.767) (.931) (.164) (.035)
(3) -8.751 9.253* 2.089 -3.183 -.718 -4.214* .541 .786*** 6.894 .446 -.148 .12
(7.83) (4.752) (3.351) (2.78) (2.233) (2.347) (.505) (.167) (5.26) (1.953) (.372) (.091)
(4) -5.3 6.527 4.274 -1.636 .697 -5.259* 1.048* .797*** 5.416 .859 -.436 .089
(8.25) (5.109) (3.718) (3.171) (2.431) (2.701) (.556) (.182) (5.67) (2.265) (.39) (.1)
(5) -6.541 1.279 -.352 -1.488 -.386 -.202 .841*** .509*** 6.33 .178 .006 .043
(4.166) (3.025) (2.193) (1.352) (.891) (.448) (.168) (.049) (4.541) (1.941) (.164) (.037)
Procedures (#)
(1) -2.305 1.007 -.387 -.339 .151 .409 .91*** .471*** .814 .272 .202* .007
(1.614) (1.234) (.776) (.875) (.543) (.421) (.161) (.051) (1.32) (.551) (.114) (.03)
(2) .084 -.146 .25 -.174 .164 .073 .31*** .281*** 1.093** -.16 .035 -.002
(.653) (.462) (.364) (.338) (.23) (.244) (.069) (.022) (.538) (.224) (.048) (.012)
(3) .429 -.173 .734 -.128 .716 -1.04* .02 .41*** 1.765 -.43 .048 -.037
(1.347) (.924) (.833) (.532) (.436) (.621) (.149) (.053) (1.166) (.481) (.109) (.029)
(4) .579 -.455 1.108 .12 .901* -1.107 .218 .449*** .883 -.463 -.04 -.029
(1.459) (.967) (.894) (.593) (.479) (.718) (.163) (.058) (1.296) (.53) (.118) (.031)
(5) -.364 -.361 .379 -.433 .201 .039 .239*** .208*** 1.062 -.16 .045 -.004
(.735) (.61) (.512) (.322) (.202) (.109) (.045) (.015) (.894) (.46) (.048) (.013)
Mortality
(1) .045 -.039 -.02 .04* -.01 .015** -.001 0 0 .003 0 0
(.07) (.044) (.029) (.022) (.016) (.007) (.003) (.001) (.051) (.014) (.002) (0)
(2) -.003 -.027 .007 .009 .006 -.002 -.004*** 0 -.008 -.014** -.001 0
(.027) (.017) (.013) (.009) (.005) (.004) (.001) (0) (.019) (.006) (.001) (0)
(3) .033 -.056 .018 .004 .007 -.008 -.006** .001 -.064 -.023** 0 0
(.057) (.035) (.025) (.018) (.01) (.01) (.003) (.001) (.04) (.01) (.002) (0)
(4) .037 -.018 .025 -.005 .016 -.013 -.006* .001 -.069 -.024** -.001 0
(.06) (.037) (.027) (.021) (.011) (.011) (.003) (.001) (.043) (.011) (.002) (0)
(5) .012 -.027 .005 .018** -.001 0 -.002** 0 -.063* -.016* .001 0
(.031) (.023) (.016) (.009) (.005) (.002) (.001) (0) (.033) (.008) (.001) (0)
Notes: Parametric regressions within different intervals around birth weight thresholds always include control variables, hospital-fixed effects and
are restricted to first-day-survivors. Coefficient of binary variable indicating observations below threshold. (Robust) Standard errors in parentheses.
NL: Number of observations left to/below the threshold . NR: Number of observations right to/above the threshold. Control variables include
gender, (extreme) prematurity, multiples, asphyxia, IRDS, in-patient ward/midwife/doctor, maternal smoking/alcohol consumption/ drug use and
years. [Specification] (1) uses a second order birth weight polynomial (fitted separately on each side of the threshold) and includes observations
within a ±100 gram bandwidth around the threshold, but excludes observations within a ±10 gram bandwidth around the threshold. (2) uses a first
order birth weight polynomial (fitted separately on each side of the threshold) and includes observations within a ±100 gram bandwidth around the
threshold. (3) uses a third order birth weight polynomial (fitted separately on each side of the threshold) and includes observations within a ±100
gram bandwidth around the threshold. (4) uses a second order birth weight polynomial (fitted separately on each side of the threshold) and includes
observations within a ±50 gram bandwidth around the threshold. (5) uses a second order birth weight polynomial (fitted separately on each side of
the threshold) and includes all observations between two thresholds. For variable definitions see table 1. Source:. Own calculations based on the
DRG-Statistic.
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Notes: Development of case-weights for the six DRG-severity groups defined in tables A.1 for
the year 2008. Source: DRG catalogue 2008
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Notes: Distribution of birth weights below 3000 grams in the years 2005-2011. Red lines
mark birth weight thresholds in the G-DRG system. All birth weight bins with less than three
observations were omitted due to confidentiality. This does not change the look of the graph.
Source: Own calculations based on the DRG-Statistic.
Figure 3: Length of stay (days) at highest thresholds (Years 2005-2011)
Notes: Circles show mean values in 10 gram intervals. Green lines are fitted values using all
observations. Excludes newborns who died on their first day of life. Source: Own calculations
based on the DRG-Statistic.
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Figure 4: Number of procedures at highest thresholds (Years 2005-2011)
Notes: Circles show mean values in 10 gram intervals. Green lines are fitted values using all
observations. Excludes newborns who died on their first day of life. Source: Own calculations
based on the DRG-Statistic.
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Table A.1: DRG-Severity Groups for Newborns in Germany (2005-2011)
2005
<600 600 - 749 750 - 874 875 - 999 1000 - 1249 1250 - 1499 1500 - 1999 2000 - 2499 > 2499
Severity group 1
P61A P61B P62A P62B
P63Z P64Z
P65D P66D P67D
Severity group 2 P65C P66C P67C
Severity group 3 P65B P66B P67B
Severity group 4 P65A P66A P67A
Severity group 5 P03D P04C P05C P06C
Severity group 6 P03B P04B P05B P06B
2006-2010
<600 600 - 749 750 - 874 875 - 999 1000 - 1249 1250 - 1499 1500 - 1999 2000 - 2499 > 2499
Severity group 1
P61B P61D P62B P62D P63Z P64Z
P65D P66D P67D
Severity group 2 P65C P66C P67C
Severity group 3 P65B P66B P67B
Severity group 4 P65A P66A P67A
Severity group 5
P61A P61C P62A P62C
P03C P04C P05C P06C
Severity group 6 P03B P04B P05B P06B
2011
<600 600 - 749 750 - 874 875 - 999 1000 - 1249 1250 - 1499 1500 - 1999 2000 - 2499 > 2499
Severity group 1
P61B P61D P62B P62C P63Z P64Z
P65D P66D P67D
Severity group 2 P65C P66C P67C
Severity group 3 P65B P66B P67B
Severity group 4 P65A P66A P67A
Severity group 5
P61A P61C P62A
P03C P04C P05C P06C
Severity group 6 P03B P04B P05B P06B
Notes: Severity groups and birth weight thresholds in gram. Within each severity group, birth weight is the only grouping criterion. This
table is based on simulations, performed using the G-DRG Webgrouper: http://drg.uni-muenster.de/index.php?option=com_webgrouper&view=
webgrouper&Itemid=26
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Table A.2: Differences above and below threshold Severity groups, 2005-2011
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Outcomes
Length of stay (days)
Severity group 1 23.647*** 3.071*** .263*** .313*** .067***
(2.96) (.324) (.033) (.119) (.019)
Severity group 2 6.991*** 1.775*** 1.7*** .515*** .285***
-2.431 5.338** 3.098* 16.178*** 1.631* (.883) (.247) (.126) -1.09 1.534* (.189) (.104)
Severity group 3 (3.838) (2.492) (1.684) (2.893) (.938) 1.595* 1.623*** 1.455*** (2.76) (.886) .953** 1.12***
(.933) (.429) (.307) (.41) (.271)
Severity group 4 -7.452*** 2.305*** .52 .122 1.999**
(2.228) (.849) (.781) (.947) (.976)
Severity group 5 11.136*** -1.901 -11.935 -3.819* -2.74 4.492** -1.825 -5.328***
-4.618 7.211 5.525 (3.23) (2.127) (10.246) (2.236) (2.905) 9.657* (1.945) (2.215) (1.821)
Severity group 6 (5.685) (4.598) (4.281) 14.056*** -1.721 3.246 1.282 -.784 (5.811) 3.583* -3.681 -3.893
(3.229) (2.432) (3.023) (2.83) (3.499) (2.168) (2.888) (2.535)
Others 3.019 1.758 .817 -38.702*** 5.906 -6.832* .18 -.418 -.681 3.456 .362 -.377
(2.169) (2.775) (.768) (3.457) (4.786) (3.653) (1.419) (.923) (2.1) (4.189) (1.137) (.749)
Procedures (#)
Severity group 1 5.233*** .671*** .082*** .026 .019***
(.227) (.069) (.01) (.028) (.006)
Severity group 2 2.085*** .335*** .459*** .139*** .106***
-.132 .477 .617* 3.702*** .438** (.187) (.057) (.04) -.1 -.148 (.046) (.04)
Severity group 3 (.533) (.445) (.338) (.467) (.215) -.25 .209* .947*** (.447) (.224) .089 .209**
(.222) (.115) (.091) (.115) (.088)
Severity group 4 -1.461*** .253 .318 -.01 .341
(.374) (.236) (.243) (.242) (.287)
Severity group 5 5.917*** .134 -.986 -.712 -.14 -.019 .267 -.969
-.636 -.546 1.569 (.682) (.485) (2.049) (.872) (.809) 1.693 (.476) (.651) (.787)
Severity group 6 (1.18) (1.156) (1.169) 4.159*** .723 .208 -.492 -.883 (1.105) 1.202** -.545 -1.49**
(.727) (.536) (1.417) (.79) (1.011) (.574) (1.094) (.719)
Others .598 1.413 .588 -5.452*** 1.399 -1.772* -.092 .223 -.356 -.053 .112 -.185
(.58) (1.303) (.618) (.904) (.924) (1.003) (.4) (.297) (.708) (1.028) (.379) (.267)
Mortality
Severity group 1 .001* 0 0 0 0
(.001) (0) (0) (0) (0)
Severity group 2 .001* 0 0 0 0
.026 -.031 .005 .011 .001 (.001) (0) (0) .015 -.003 (0) (0)
Severity group 3 (.031) (.019) (.012) (.015) (.001) .001* 0 0 (.023) (.002) 0 0
(.001) (0) (0) (0) (0)
Severity group 4 .001* .002 -.019** -.005 0
(.001) (.002) (.008) (.003) (0)
Severity group 5 .116*** .003 .002 0 -.009 -.001 0 0
.027 -.082** .04 (.017) (.003) (.002) (0) (.027) .017 (.013) (0) (0)
Severity group 6 (.043) (.037) (.035) .116*** -.004 .023*** -.018 .021 (.036) -.008 -.014 0
(.017) (.016) (.007) (.023) (.015) (.014) (.029) (0)
Others .016 -.08 .115* .07 -.076** -.145*** -.036*** -.009 .014 -.022 .003 -.006
(.041) (.063) (.068) (.042) (.036) (.039) (.013) (.008) (.057) (.038) (.012) (.008)
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Table A.2: Differences above and below threshold by Severity group, 2005-2011 (continued)
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Health-related controls
Male births
Severity group 1 -.051 -.034 .004 -.015 0
(.145) (.029) (.007) (.015) (.005)
Severity group 2 .078* .008 .021 .017 .004
.055 -.063* -.037 .065 0 (.045) (.017) (.013) .014 -.043 (.014) (.013)
Severity group 3 (.041) (.036) (.03) (.061) (.033) -.003 0 .041** (.034) (.032) -.003 .003
(.044) (.024) (.019) (.023) (.02)
Severity group 4 -.032 .006 .062* -.013 -.012
(.058) (.04) (.036) (.039) (.041)
Severity group 5 .161** -.107* -.028 .117 -.071 .049 -.074 -.067
.016 -.015 .001 (.073) (.056) (.093) (.082) (.09) .019 (.062) (.107) (.108)
Severity group 6 (.048) (.049) (.053) .045 .018 .074 .092 -.073 (.043) .011 .039 -.104
(.067) (.052) (.092) (.082) (.086) (.053) (.091) (.098)
Others -.048 .029 .071 -.021 .004 .036 -.028 -.023 .091 -.099* .016 .012
(.05) (.064) (.07) (.051) (.047) (.05) (.028) (.024) (.058) (.053) (.028) (.024)
Extreme Prematurity
Severity group 1 .012*** 0 0 0 0
(.002) (0) (0) (0) (0)
Severity group 2 -.012 -.002 -.001 .002 .001
.013 -.006 .053* .245*** -.006 (.014) (.002) (.001) -.005 -.006 (.002) (.001)
Severity group 3 (.04) (.036) (.03) (.03) (.013) -.01 .001 -.004 (.034) (.012) 0 -.002*
(.013) (.002) (.002) (.002) (.001)
Severity group 4 -.014 -.01 -.016** .009 .004
(.018) (.008) (.007) (.007) (.004)
Severity group 5 .154** .025 -.005 .008 -.045 0 0 0
-.026 .036 .044 (.06) (.025) (.034) (.008) (.032) .003 (.034) (0) (0)
Severity group 6 (.046) (.048) (.053) .146*** -.031 -.003 -.004 0 (.043) .079** -.003 0
(.056) (.032) (.033) (.024) (0) (.034) (.027) (0)
Others -.008 .087 .053 -.041 .057** .011 .008 .002 -.003 .009 -.009 -.002
(.05) (.064) (.064) (.047) (.028) (.018) (.008) (.008) (.06) (.034) (.007) (.006)
Prematurity
Severity group 1 .394*** .157*** -.019*** -.005 .013***
(.125) (.03) (.005) (.014) (.003)
Severity group 2 .031 .056*** -.03** -.01 .028**
-.037 .031 -.004 -.037 -.003 (.045) (.017) (.013) -.03 -.018 (.014) (.013)
Severity group 3 (.032) (.031) (.028) (.061) (.032) .066 .032 -.066*** (.028) (.032) .006 .057***
(.044) (.023) (.019) (.023) (.02)
Severity group 4 -.044 .028 .031 .065* .017
(.054) (.038) (.036) (.038) (.041)
Severity group 5 -.092 -.047 -.083 -.053 -.306*** -.006 .078 -.144
.038 .006 .017 (.074) (.056) (.087) (.075) (.082) .025 (.061) (.102) (.105)
Severity group 6 (.037) (.039) (.049) -.119* -.019 -.138* .156* -.061 (.037) -.081 -.038 -.02
(.067) (.051) (.078) (.081) (.086) (.052) (.089) (.097)
Others -.015 -.022 -.006 .027 .031 -.023 .052* -.021 -.008 -.107** .025 .024
(.036) (.047) (.059) (.047) (.048) (.05) (.028) (.023) (.044) (.052) (.027) (.023)
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Table A.2: Differences above and below threshold by Severity group, 2005-2011 (continued)
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Health-related controls (continued)
Twin births
Severity group 1 .026 -.005 .021*** .005 .014***
(.125) (.029) (.005) (.014) (.003)
Severity group 2 -.022 .009 .146*** .008 .008
.022 .007 -.033 -.018 -.035 (.042) (.016) (.009) .025 -.038 (.013) (.006)
Severity group 3 (.03) (.027) (.025) (.051) (.029) .039 -.023 -.173*** (.025) (.028) .011 .035**
(.038) (.022) (.017) (.021) (.017)
Severity group 4 .016 .016 .057** -.026 .03
(.051) (.034) (.024) (.031) (.023)
Severity group 5 -.012 .04 -.045 0 -.078 .172*** .035 -.192***
.001 -.039 -.062 (.062) (.049) (.089) (.073) (.073) .061* (.059) (.095) (.055)
Severity group 6 (.037) (.038) (.045) -.073 .04 -.099 .075 -.089 (.035) .017 -.027 -.019
(.061) (.044) (.088) (.058) (.063) (.048) (.063) (.045)
Others -.012 -.001 -.053 -.072* -.021 -.022 .026 .009 -.058 .033 .011 .025**
(.039) (.052) (.051) (.038) (.039) (.041) (.021) (.014) (.042) (.043) (.021) (.012)
Multiple births
Severity group 1 .047*** .004 .001** .002 0
(.004) (.005) (0) (.001) (0)
Severity group 2 -.002 -.006 0 .002 0
-.009 .001 -.016 -.023 -.006 (.02) (.005) (.001) -.021** .007 (.003) (0)
Severity group 3 (.012) (.013) (.01) (.028) (.015) -.005 .006 .001 (.009) (.015) .006 0
(.02) (.005) (.001) (.005) (.001)
Severity group 4 .021 -.003 .002 -.001 0
(.019) (.01) (.002) (.007) (0)
Severity group 5 -.047 .012 -.091 .013 0 .024 -.032 .03
-.013 .001 -.009 (.038) (.026) (.063) (.025) (0) -.004 (.025) (.022) (.03)
Severity group 6 (.013) (.016) (.016) -.063* -.036 -.036 .009 .01 (.016) .011 0 0
(.037) (.026) (.045) (.007) (.01) (.025) (0) (0)
Others .005 .013 .012 -.007 .018 .006 .003 .002 -.004 -.034*** .003 0
(.013) (.009) (.018) (.017) (.017) (.015) (.003) (.002) (.012) (.011) (.003) (0)
Asphyxia
Severity group 1 .066*** 0 0** 0 0
(.005) (0) (0) (0) (0)
Severity group 2 .041*** -.005 -.013** .001 .004
.032 -.005 -.013 .039 -.019 (.015) (.006) (.006) .021 -.01 (.006) (.007)
Severity group 3 (.029) (.024) (.019) (.029) (.017) -.001 -.008 .013 (.021) (.015) -.008 .003
(.022) (.012) (.01) (.011) (.01)
Severity group 4 -.025 -.01 .065*** -.025 .017
(.033) (.024) (.023) (.023) (.025)
Severity group 5 .018 .015 .052 -.022 .034 -.063* -.033 .03
-.004 .016 -.016 (.04) (.029) (.036) (.047) (.036) -.002 (.034) (.043) (.03)
Severity group 6 (.034) (.032) (.033) .048 .034 .039 .023 .087* (.03) -.035 .004 -.018
(.03) (.033) (.046) (.052) (.048) (.034) (.044) (.075)
Others .057* .058 .019 -.061* -.007 .025 -.036*** 0 .076* -.047* -.001 -.031***
(.033) (.041) (.045) (.033) (.032) (.026) (.014) (.012) (.042) (.028) (.013) (.012)
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Table A.2: Differences above and below threshold by Severity group, 2005-2011 (continued)
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Health-related controls (continued)
Severe asphyxia
Severity group 1 .012*** 0 0 0 0
(.002) (0) (0) (0) (0)
Severity group 2 .012*** .001 -.003 .001 .003
.012 -.019 -.004 .016 -.002 (.002) (.002) (.002) -.002 0 (.002) (.002)
Severity group 3 (.018) (.016) (.012) (.015) (.006) .012*** -.003 .001 (.012) (.008) .001 -.002
(.002) (.005) (.005) (.005) (.005)
Severity group 4 -.014 -.012 .008 .002 .011
(.018) (.012) (.014) (.013) (.014)
Severity group 5 .032*** -.011 .021*** -.03 .005 -.032** .014 .03
.015 .003 -.018 (.009) (.019) (.007) (.028) (.03) .009 (.013) (.034) (.03)
Severity group 6 (.022) (.02) (.023) .032*** .03** .007 .024 .001 (.019) -.008 .064* .008
(.009) (.013) (.033) (.026) (.024) (.023) (.036) (.041)
Others .054* .024 .055 -.007 -.019 -.004 -.016* -.01 .031 -.023 -.009 -.012
(.03) (.035) (.036) (.023) (.024) (.022) (.009) (.009) (.035) (.018) (.008) (.008)
Moderate asphyxia
Severity group 1 .052*** 0 0* 0 0
(.004) (0) (0) (0) (0)
Severity group 2 .028* -.004 -.01* -.001 .002
.017 .018 -.01 .021 -.012 (.015) (.006) (.005) .024 -.012 (.005) (.006)
Severity group 3 (.024) (.019) (.015) (.025) (.016) -.007 -.006 .011 (.018) (.013) -.01 .002
(.021) (.011) (.008) (.01) (.009)
Severity group 4 -.012 -.004 .05*** -.028 .006
(.028) (.021) (.017) (.019) (.021)
Severity group 5 -.012 .026 .03 -.001 .028 -.036 -.048* 0
-.02 .022 .002 (.039) (.022) (.035) (.038) (.02) -.007 (.03) (.027) (0)
Severity group 6 (.028) (.025) (.026) .019 .002 .062*** -.001 .096** (.025) -.035 -.048** -.027
(.029) (.03) (.011) (.047) (.044) (.026) (.023) (.066)
Others -.002 .034 -.036 -.042* .017 .026* -.02* .006 .045* -.031 .013 -.02**
(.016) (.023) (.029) (.024) (.022) (.014) (.01) (.008) (.027) (.021) (.01) (.009)
IRDS
Severity group 1 .521*** .011 .003*** 0 .001
(.01) (.008) (.001) (.003) (.001)
Severity group 2 .295*** .021 .076*** -.015 .004
.01 -.02 .02 .274*** -.009 (.039) (.013) (.01) -.037* .021 (.011) (.01)
Severity group 3 (.024) (.023) (.02) (.06) (.032) -.035 .056** .169*** (.022) (.032) .021 .03
(.044) (.024) (.018) (.023) (.019)
Severity group 4 -.076 .044 .11*** -.038 -.017
(.057) (.039) (.036) (.039) (.041)
Severity group 5 .118* -.046 .054 .158** .071 .016 .198** -.131
.006 .056* .018 (.064) (.042) (.08) (.075) (.094) -.001 (.048) (.088) (.111)
Severity group 6 (.027) (.032) (.036) -.105*** -.02 .015 .272*** .221*** (.025) .024 .109 -.112
(.032) (.03) (.062) (.079) (.084) (.032) (.087) (.097)
Others .037 .113* .025 -.277*** .107** -.063 .007 .028 -.003 -.016 .007 .023
(.048) (.063) (.066) (.049) (.048) (.046) (.022) (.019) (.059) (.053) (.022) (.019)
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Table A.2: Differences above and below threshold by Severity group, 2005-2011 (continued)
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Health-related controls (continued)
Maternal smoking
Severity group 1 .043*** .026** .005*** -.004 .001**
(.004) (.012) (.001) (.005) (.001)
Severity group 2 .011 -.01 .003 .006 .005
.007 -.004 .006 .023 .013 (.016) (.007) (.004) -.008 -.003 (.006) (.004)
Severity group 3 (.012) (.011) (.011) (.015) (.012) .028** -.003 .002 (.011) (.011) -.006 .006
(.011) (.01) (.008) (.009) (.007)
Severity group 4 .017 -.001 -.006 -.007 .001
(.019) (.018) (.014) (.016) (.015)
Severity group 5 .022*** .01 .026*** -.019 0 -.016* 0 -.019
-.013 .002 -.016 (.008) (.013) (.008) (.019) (0) -.005 (.009) (0) (.019)
Severity group 6 (.012) (.012) (.021) -.009 -.022 .014*** .014* -.037 (.014) .015 .021 .011
(.023) (.018) (.005) (.008) (.036) (.019) (.021) (.028)
Others -.017** .02* .008 -.023 .005 .004 -.008 .004 0 -.008 -.001 .002
(.008) (.011) (.008) (.015) (.003) (.003) (.006) (.004) (0) (.011) (.005) (.004)
Maternal alcohol use
Severity group 1 .002** 0 0 0 0
(.001) (0) (0) (0) (0)
Severity group 2 .002** -.001 0 0 0
0 -.002 -.002 .003** 0 (.001) (.001) (.001) -.002 .005 (.001) (0)
Severity group 3 (0) (.004) (.002) (.001) (0) .002** 0 .001 (.002) (.004) -.002 .003*
(.001) (.002) (.002) (.001) (.002)
Severity group 4 -.011 .001 0 -.005 -.002
(.013) (.005) (0) (.003) (.002)
Severity group 5 0 .003 .002 0 -.023 -.005 0 0
0 .003 .009 (0) (.003) (.002) (0) (.023) -.004 (.005) (0) (0)
Severity group 6 (0) (.003) (.006) 0 -.008 .002 0 0 (.004) 0 0 0
(0) (.008) (.002) (0) (0) (0) (0) (0)
Others 0 -.01 0 0 -.007 .002 0 -.002 0 0 -.001 .001
(0) (.01) (0) (0) (.007) (.002) (0) (.002) (0) (0) (.001) (.002)
Maternal drug use
Severity group 1 .007*** 0 0 0 0
(.002) (0) (0) (0) (0)
Severity group 2 .007*** -.001 .003 .003 -.002
-.003 -.004 .006 .003** -.002 (.002) (.002) (.002) .001 0 (.002) (.002)
Severity group 3 (.003) (.004) (.004) (.002) (.003) .007*** 0 .008 (.003) (.004) .001 .006
(.002) (.004) (.005) (.005) (.004)
Severity group 4 -.032 .018** .004 .004 .021*
(.022) (.008) (.011) (.009) (.012)
Severity group 5 -.014 0 .002 .016 0 0 0 0
0 0 .005 (.019) (0) (.002) (.011) (0) 0 (0) (0) (0)
Severity group 6 (0) (0) (.005) .005 -.012 .008** -.022 .01 (0) -.011* 0 -.027
(.004) (.012) (.004) (.022) (.01) (.007) (0) (.019)
Others 0 .007 0 0 -.004 0 0 .003 0 .004 -.001 0
(0) (.007) (0) (0) (.007) (0) (.003) (.003) (0) (.008) (.005) (.003)
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Table A.2: Differences above and below threshold by Severity group, 2005-2011 (continued)
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Hospital-related controls
In-patient ward
Severity group 1 -.167 -.024 -.012*** -.007 -.005
(.108) (.018) (.004) (.01) (.003)
Severity group 2 0 -.005** -.024*** .002 -.012**
.003 0 0 0 0 (0) (.002) (.005) 0 0 (.003) (.006)
Severity group 3 (.003) (0) (0) (0) (0) 0 .001 -.01*** (0) (0) -.002 -.013***
(0) (.001) (.004) (.002) (.005)
Severity group 4 0 0 0 -.002 .004
(0) (0) (0) (.002) (.004)
Severity group 5 0 0 0 0 0 0 0 0
.005 0 0 (0) (0) (0) (0) (0) 0 (0) (0) (0)
Severity group 6 (.005) (0) (0) 0 0 0 0 0 (0) 0 0 0
(0) (0) (0) (0) (0) (0) (0) (0)
Others -.004 -.033 -.044 .022 -.028* -.016 -.023 -.037** .007 .003 -.026 -.01
(.014) (.027) (.028) (.017) (.017) (.023) (.016) (.015) (.017) (.015) (.017) (.018)
In-patient midwife
Severity group 1 -.079 -.031** -.009** .005 -.002
(.08) (.012) (.004) (.008) (.003)
Severity group 2 .004*** -.01*** -.015*** 0 -.003
0 .001 -.001 .001 -.001 (.001) (.003) (.005) 0 -.002 (.004) (.006)
Severity group 3 (.005) (.001) (.003) (.001) (.005) .004*** .006** -.012** (0) (.004) -.003 -.014**
(.001) (.003) (.005) (.004) (.005)
Severity group 4 .004*** -.001 -.007 .009 .012
(.001) (.007) (.006) (.007) (.011)
Severity group 5 .003 0 0 0 0 0 0 0
.005 .003 .005 (.003) (0) (0) (0) (0) 0 (0) (0) (0)
Severity group 6 (.005) (.003) (.005) .003 .005 .004 0 .021 (0) 0 0 0
(.003) (.003) (.003) (0) (.015) (0) (0) (0)
Others -.009 -.019 -.072 .014 -.029 .032 .022 -.029* .021 -.012 0 .019
(.018) (.033) (.045) (.019) (.025) (.024) (.018) (.016) (.029) (.021) (.019) (.018)
In-patient doctor
Severity group 1 -.249** -.034* -.015*** -.004 -.003
(.125) (.018) (.004) (.01) (.003)
Severity group 2 -.007 -.004 -.024*** .001 -.008
0 0 -.007 .001 .001 (.008) (.003) (.005) .006 -.003 (.004) (.006)
Severity group 3 (.005) (0) (.005) (.001) (.001) .001 -.002 -.013*** (.004) (.002) 0 -.014***
(.001) (.003) (.004) (.003) (.005)
Severity group 4 .001 .006* -.001 -.007* .002
(.001) (.003) (.004) (.004) (.005)
Severity group 5 .005 .003 0 0 .014 0 0 0
.005 .005 -.007 (.004) (.003) (0) (0) (.014) -.011 (0) (0) (0)
Severity group 6 (.005) (.004) (.014) -.01 .01** .006* 0 .01 (.008) -.004 -.012 -.014
(.016) (.005) (.004) (0) (.01) (.004) (.012) (.014)
Others .007 -.01 -.028 .029*** -.004 -.024 -.004 -.037** .025* .003 -.025 -.001
(.009) (.02) (.022) (.011) (.011) (.023) (.015) (.015) (.014) (.015) (.015) (.017)
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Table A.2: Differences above and below threshold by Severity group, 2005-2011 (continued)
reimbursement relevant thresholds placebo thresholds
T = 600 T = 750 T = 875 T = 1000 T = 1250 T = 1500 T = 2000 T = 2500 T = 700 T = 1300 T = 2200 T = 2700
Number of births
1 - NL 2497 404 7988 1509 16474
NR 12 778 13960 2984 29625
2 - NL 2497 2384 3575 1929 2354
NR 294 745 641 1483 813 124 1439 2790 361 365 3130 4061
3 - NL 304 264 472 70 328 2497 1327 1402 528 636 756 1041
NR 135 670 1312 1201 1718
4 - NL 2497 536 463 257 227
NR 77 225 317 433 406
5 - NL 370 302 423 125 71 99 33 33
NR 218 373 221 52 98 30 53 44 250 186 63 52
6 - NL 225 142 147 370 419 484 216 97 275 132 47 41
NR 65 118 31 45 52 262 84 74
Others - NL 170 150 127 243 423 477 673 836 121 135 514 655
NR 234 101 84 160 149 129 596 909 170 264 882 1158
Notes: Difference between means below and above birth weight threshold T within a ±25 gram bandwidth in each Severity group (X̄below-X̄above). (Robust )Standard
errors in parentheses below mean difference . NL: Number of observations left/below threshold within 25 gram bandwidth. NR: Number of observations right/above
threshold within 25 gram bandwidth. *** p<0.01; ** p<0.05 and * p<0.1. For variable definition see table 1 Source: Own calculations based on the DRG-Statistic.
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